Ramsay Health Care (AU:RHC)
ASX:RHC
RHC Stock Chart & Stats
AU$38.92
-AU$0.38(-1.09%)
At close: 4:00 PM EST
AU$38.92
-AU$0.38(-1.09%)
Day’s Range― - ―
52-Week RangeAU$30.39 - AU$44.73
Previous CloseN/A
Volume335.68K
Average Volume (3M)804.76K
Market Cap
AU$8.94B
Enterprise ValueAU$26.01B
Total Cash (Recent Filing)AU$469.00M
Total Debt (Recent Filing)AU$17.53B
Price to Earnings (P/E)12.3
Beta1.18
Next Earnings
Aug 27, 2026EPS Estimate
0.68Next Dividend Ex-DateN/A
Dividend Yield2.25%
Share Statistics
EPS (TTM)0.71
Shares Outstanding230,829,800
10 Day Avg. Volume739,925
30 Day Avg. Volume804,756
Financial Highlights & Ratios
PEG Ratio-12.47
Price to Book (P/B)5.91
Price to Sales (P/S)1.67
P/FCF Ratio42.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$41.25Price Target Upside5.98% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.37
Revenue Forecast (FY)AU$18.96B
Bulls Say, Bears Say
Bulls Say
Market-leading Australia OperationsRamsay's scale and momentum in Australia drive durable revenue and margin tailwinds: rising admissions, stronger theatre utilisation and case acuity support sustainable procedure volumes, higher utilisation of fixed assets, and recurring insurer/government payer relationships that underpin predictable cash generation.
Improving Cash Conversion And RefinancingA material improvement in operating cash flow and successful refinancing (extended tenor, lower margin, majority hedged) enhances financial flexibility. Stronger cash conversion supports debt servicing, targeted capex, and ongoing dividends, reducing refinancing risk over the medium term.
Active Capital Discipline And De‑riskingManagement is prioritising capital efficiency and structural simplification via trimmed capex, a proposed Ramsay Sante in‑specie distribution and selective accretive M&A. These moves should reduce group concentration, sharpen strategic focus and free cash for deleveraging over multiple quarters.
Bears Say
High Group Leverage And Weak ROEElevated leverage and a collapse in ROE indicate constrained capital returns and limited balance sheet flexibility. High net debt relative to equity increases sensitivity to interest rates and refinancing cycles, reducing resilience to earnings shocks over the next several quarters.
Material Regional Funding And Operational RisksSignificant exposure to region-specific funding and operational issues creates durable revenue volatility: UK NHS budget uncertainty, Elysium's prolonged lower occupancy and French subsidy/tariff pressures can persist for multiple quarters and depress margins while turnaround actions take time to restore profitability.
Sharp Margin DeteriorationA pronounced fall in net margin signals structural pressure on profitability from cost inflation, payor indexation gaps and regional earnings shortfalls. Sustained margin weakness would impair free cash flow and limit reinvestment or deleveraging capacity absent operational improvement or better funding terms.
Ramsay Health Care News
RHC FAQ
What was Ramsay Health Care’s price range in the past 12 months?
Ramsay Health Care lowest share price was AU$30.39 and its highest was AU$44.73 in the past 12 months.
What is Ramsay Health Care’s market cap?
Ramsay Health Care’s market cap is AU$8.94B.
When is Ramsay Health Care’s upcoming earnings report date?
Ramsay Health Care’s upcoming earnings report date is Aug 27, 2026 which is in 146 days.
How were Ramsay Health Care’s earnings last quarter?
Ramsay Health Care released its earnings results on Feb 25, 2026. The company reported AU$0.71 earnings per share for the quarter, beating the consensus estimate of AU$0.597 by AU$0.113.
Is Ramsay Health Care overvalued?
According to Wall Street analysts Ramsay Health Care’s price is currently Undervalued.
Does Ramsay Health Care pay dividends?
Ramsay Health Care pays a Semiannually dividend of AU$0.4 which represents an annual dividend yield of 2.25%. See more information on Ramsay Health Care dividends here
What is Ramsay Health Care’s EPS estimate?
Ramsay Health Care’s EPS estimate is 0.68.
How many shares outstanding does Ramsay Health Care have?
Ramsay Health Care has 230,829,800 shares outstanding.
What happened to Ramsay Health Care’s price movement after its last earnings report?
Ramsay Health Care reported an EPS of AU$0.71 in its last earnings report, beating expectations of AU$0.597. Following the earnings report the stock price went up 10.348%.
Which hedge fund is a major shareholder of Ramsay Health Care?
Currently, no hedge funds are holding shares in AU:RHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ramsay Health Care Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$41.25 (5.98% Upside)
AU$41.25 (5.98% Upside)
Blogger Sentiment
Bullish
AU:RHC Sentiment 85%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $451.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.10%
12-Months-Change
Fundamentals
Return on Equity
5.75%
Trailing 12-Months
Asset Growth
13.13%
Trailing 12-Months
Company Description
Ramsay Health Care
Ramsay Health Care Limited owns and operates hospitals. The company also offers health care services to public and private patients. It operates facilities in approximately 532 locations in the Asia Pacific, the United Kingdom, France, and Nordics. The company was founded in 1964 and is based in Sydney, Australia.
RHC Company Deck
RHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Positive overall: the call emphasizes strong, broad-based underlying profit growth driven by Australia, improved cash flow, active capital-discipline measures, and material operational progress on the transformation agenda. These positives are tempered by clear and material regional challenges — notably UK NHS funding uncertainty, Elysium underperformance, French funding headwinds and elevated leverage in Ramsay Sante — which management is actively addressing through turnaround programs, refinancing and a proposed demerger. The balance of the narrative is constructive but cautious, with meaningful risks to monitor.View all AU:RHC earnings summariesRHC Stock 12 Month Forecast
Average Price Target
AU$41.25
▲(5.98% Upside)
Technical Analysis
Healius Limited
―
Regis Healthcare Ltd.
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Options Prices
Currently, No data available
---